Posts Tagged ‘Intellia’

Nessan Bermingham

Nessan Bermingham is the CEO, president, and founder of Intellia Therapeutics, a leading gene-editing company. Most recently, Nessan was a venture partner at Atlas Venture and was previously the CEO of Tal Medical, a medical device company spun out of Harvard Medical School. Nessan has more than 15 years of experience in life sciences investments,Read more..